FDA Approves New Treatment Option for Patients with ALS
SILVER SPRING, Md., Sept. 29, 2022. The U.S. Food and Drug Administration today approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), com
FDA Approves Omlonti
FDA Approves Omlonti (omidenepag isopropyl ophthalmic solution) for Reduction of Elevated Intraocular Pressure in Primary Open-Angle Glaucoma or Ocular Hypertension
EMERYVILLE, Calif. & UBE, Japan--(BUSINESS WIRE) September 26, 20
Acupuncture May Ease Anxiety in Patients With Parkinson Disease
THURSDAY, Sept. 29, 2022 -- Acupuncture may help treat anxiety in patients with Parkinson disease and anxiety, according to a study published online Sept. 21 in JAMA Network Open.
Jing-qi
FDA Approves Vtama
FDA Approves Vtama (tapinarof) Cream for the Treatment of Plaque Psoriasis in Adults
LONG BEACH, Calif., and BASEL, Switzerland, May 24, 2022 — Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializ
Drug Therapy for Peds Psych Disorders, Later SUD Risk Examined
FRIDAY, May 27, 2022 -- Pharmacotherapy for pediatric psychiatric disorders possibly may reduce the risk for later substance use disorder (SUD), according to a review published online May 17
Exposure to Air Pollution Linked to Severe SARS-CoV-2 Outcomes
FRIDAY, May 27, 2022 -- Chronic exposure to air pollution, especially ground-level ozone (O3), may contribute to severe outcomes after severe acute respiratory syndrome coronavirus 2 (SARS-Co